Lördag 24 Oktober | 18:02:42 Europe / Stockholm
Est. tid*
2027-04-19 N/A Årsstämma
2027-04-16 07:00 Kvartalsrapport 2027-Q1
2027-01-28 12:00 Bokslutskommuniké 2026
2026-10-22 - Kvartalsrapport 2026-Q3
2026-07-14 - Kvartalsrapport 2026-Q2
2026-04-23 - X-dag ordinarie utdelning ARJO B 0.95 SEK
2026-04-22 - Årsstämma
2026-04-22 - Kvartalsrapport 2026-Q1
2026-01-30 - Bokslutskommuniké 2025
2025-10-22 - Kvartalsrapport 2025-Q3
2025-07-11 - Kvartalsrapport 2025-Q2
2025-04-30 - X-dag ordinarie utdelning ARJO B 0.95 SEK
2025-04-29 - Årsstämma
2025-04-29 - Kvartalsrapport 2025-Q1
2025-01-30 - Bokslutskommuniké 2024
2024-10-17 - Kvartalsrapport 2024-Q3
2024-07-12 - Kvartalsrapport 2024-Q2
2024-04-19 - X-dag ordinarie utdelning ARJO B 0.90 SEK
2024-04-18 - Årsstämma
2024-04-18 - Kvartalsrapport 2024-Q1
2024-01-30 - Bokslutskommuniké 2023
2023-10-19 - Kvartalsrapport 2023-Q3
2023-07-13 - Kvartalsrapport 2023-Q2
2023-07-12 - Kvartalsrapport 2023-Q2
2023-04-21 - X-dag ordinarie utdelning ARJO B 0.85 SEK
2023-04-20 - Årsstämma
2023-04-20 - Kvartalsrapport 2023-Q1
2023-01-25 - Bokslutskommuniké 2022
2022-10-28 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-04-25 - X-dag ordinarie utdelning ARJO B 1.15 SEK
2022-04-22 - Årsstämma
2022-04-22 - Kvartalsrapport 2022-Q1
2022-02-03 - Bokslutskommuniké 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-04-28 - X-dag ordinarie utdelning ARJO B 0.85 SEK
2021-04-27 - Årsstämma
2021-04-27 - Kvartalsrapport 2021-Q1
2021-02-03 - Bokslutskommuniké 2020
2020-10-28 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-06-30 - X-dag ordinarie utdelning ARJO B 0.65 SEK
2020-06-29 - Årsstämma
2020-04-27 - Kvartalsrapport 2020-Q1
2020-02-04 - Bokslutskommuniké 2019
2019-10-22 - Kvartalsrapport 2019-Q3
2019-07-18 - Kvartalsrapport 2019-Q2
2019-05-08 - X-dag ordinarie utdelning ARJO B 0.55 SEK
2019-05-07 - Årsstämma
2019-05-07 - Kvartalsrapport 2019-Q1
2019-02-04 - Bokslutskommuniké 2018
2018-10-22 - Kvartalsrapport 2018-Q3
2018-07-19 - Kvartalsrapport 2018-Q2
2018-05-07 - X-dag ordinarie utdelning ARJO B 0.50 SEK
2018-05-04 - Årsstämma
2018-05-04 - Kvartalsrapport 2018-Q1
2018-01-29 - Bokslutskommuniké 2017
LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Arjo är verksamt inom medicinteknikbranschen och fokuserar på utveckling, tillverkning och distribution av medicinsk utrustning för patienthantering och rehabilitering. Bolagets produkter riktar sig till sjukvårdsinstitutioner och vårdhem. Verksamheten är global med en huvudsaklig närvaro i Europa, Nordamerika och Asien. Arjo grundades år 1957 och har sitt huvudkontor i Malmö.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Arjo's interim report January-September 2026

2026-10-22 07:00:00

"With 6% organic growth in the quarter, we continue to grow and strengthen our profitability. Our focus now is on turning our strategy into results and gradually building a stronger Arjo for the future," says Andréas Elgaard, President & CEO of Arjo.

 

July-September 2026 in brief

  • Net sales increased to SEK 2,849 M (2,646).
    Net sales grew organically by 6.0%.
  • The gross margin increased to 43.0% (41.1).
  • Adjusted EBITDA increased to SEK 523 M (436).
  • Adjusted operating profit increased to SEK 247 M (165).
  • Profit after financial items amounted to SEK 104 M (111).
  • Earnings per share before and after dilution amounted to SEK 0.21 (0.30).
  • Cash flow from operations rose to SEK 485 M (446), corresponding to a cash conversion of 100.4% (105.0).
  • A revaluation of the holdings in Atlas Mobility and Veplas of SEK 62 M was charged to net financial items.
  • New segment reporting based on the following: Europe, North America and International. Restated historical comparative figures are available on Arjo's website.
  • Strengthening of Arjo Management Team, read more on page 5.
  • Arjo's new strategic direction was presented at the Capital Markets Day, including a commitment to improve EBIT by approximately SEK 350 M versus 2025.

 

Telephone conference

Fund managers, analysts and media are invited to participate in a conference call and presentation of the report on October 22 at 08:00 CEST via the following link: https://events.inderes.com/arjo/q3-report-2026

Those who wish to ask questions verbally during the teleconference will need to register via the link below. A phone number and a conference ID will be provided after registration in order to access the conference. Link to registration: https://events.inderes.com/arjo/q3-report-2026/dial-in

Alternatively, use the following link to download the presentation: https://www.arjo.com/int/about-us/investors/reports--presentations/2026/

A recorded version of the conference is accessible for three years via the following link: https://events.inderes.com/arjo/q3-report-2026

 

For more information, please contact:

Maria Nilsson, EVP Communication & Public Relations
+46 734 244 515

maria.nilsson@arjo.com  


Erik Roslund, Investor Relations & Corporate Communications Manager

+46 768 996 303

erik.roslund@arjo.com


 

This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CEST on October 22, 2026.


About Arjo

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions for patient transfers, hygiene, disinfection, diagnostics, treating leg ulcers, prevention of pressure injuries and deep vein thrombosis, and our medical beds are all designed to promote mobility, safety and dignity in all care situations. With approximately 7 000 people worldwide and almost 70 years of caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com